nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—ABCB1—Ezetimibe—atherosclerosis	0.163	0.267	CbGbCtD
Triflupromazine—ABCB1—Simvastatin—atherosclerosis	0.152	0.248	CbGbCtD
Triflupromazine—ABCB1—Pravastatin—atherosclerosis	0.148	0.243	CbGbCtD
Triflupromazine—ABCB1—Lovastatin—atherosclerosis	0.148	0.243	CbGbCtD
Triflupromazine—Cinacalcet—CASR—atherosclerosis	0.00862	0.258	CrCbGaD
Triflupromazine—Isothipendyl—HRH1—atherosclerosis	0.00317	0.0951	CrCbGaD
Triflupromazine—Aceprometazine—HRH1—atherosclerosis	0.00275	0.0823	CrCbGaD
Triflupromazine—Methdilazine—HRH1—atherosclerosis	0.00254	0.0762	CrCbGaD
Triflupromazine—Alimemazine—HRH1—atherosclerosis	0.00186	0.0556	CrCbGaD
Triflupromazine—Mequitazine—HRH1—atherosclerosis	0.0016	0.0478	CrCbGaD
Triflupromazine—Mesoridazine—HRH1—atherosclerosis	0.00112	0.0336	CrCbGaD
Triflupromazine—Prochlorperazine—HRH1—atherosclerosis	0.00109	0.0325	CrCbGaD
Triflupromazine—Fluphenazine—HRH1—atherosclerosis	0.000982	0.0294	CrCbGaD
Triflupromazine—Propiomazine—HRH1—atherosclerosis	0.000944	0.0283	CrCbGaD
Triflupromazine—Chlorprothixene—HRH1—atherosclerosis	0.000894	0.0268	CrCbGaD
Triflupromazine—Thioridazine—HRH1—atherosclerosis	0.000846	0.0253	CrCbGaD
Triflupromazine—Methotrimeprazine—HRH1—atherosclerosis	0.000807	0.0242	CrCbGaD
Triflupromazine—Promethazine—HRH1—atherosclerosis	0.000795	0.0238	CrCbGaD
Triflupromazine—Trifluoperazine—HRH1—atherosclerosis	0.000785	0.0235	CrCbGaD
Triflupromazine—Perphenazine—HRH1—atherosclerosis	0.000776	0.0233	CrCbGaD
Triflupromazine—Desipramine—HRH1—atherosclerosis	0.000722	0.0216	CrCbGaD
Triflupromazine—Promazine—HRH1—atherosclerosis	0.0007	0.021	CrCbGaD
Triflupromazine—Chlorpromazine—HRH1—atherosclerosis	0.000616	0.0185	CrCbGaD
Triflupromazine—Imipramine—HRH1—atherosclerosis	0.000613	0.0184	CrCbGaD
Triflupromazine—Acepromazine—ALB—atherosclerosis	0.000273	0.00817	CrCbGaD
Triflupromazine—Thioproperazine—ALB—atherosclerosis	0.000267	0.00799	CrCbGaD
Triflupromazine—Pipotiazine—ALB—atherosclerosis	0.000262	0.00786	CrCbGaD
Triflupromazine—Clomipramine—ALB—atherosclerosis	0.000207	0.00621	CrCbGaD
Triflupromazine—Chlorpromazine—ALB—atherosclerosis	0.000142	0.00426	CrCbGaD
Triflupromazine—HTR2B—Signaling Pathways—PRKCG—atherosclerosis	6.77e-05	0.00019	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EDN1—atherosclerosis	6.77e-05	0.00019	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PARP1—atherosclerosis	6.76e-05	0.00019	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PLAT—atherosclerosis	6.76e-05	0.00019	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GHRL—atherosclerosis	6.76e-05	0.00019	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	6.75e-05	0.00019	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ALOX5—atherosclerosis	6.75e-05	0.00019	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCL5—atherosclerosis	6.71e-05	0.000189	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PARP1—atherosclerosis	6.67e-05	0.000188	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PLAT—atherosclerosis	6.67e-05	0.000188	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GHRL—atherosclerosis	6.67e-05	0.000188	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PPARA—atherosclerosis	6.64e-05	0.000187	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—F2—atherosclerosis	6.63e-05	0.000187	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SPP1—atherosclerosis	6.59e-05	0.000186	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—LPL—atherosclerosis	6.57e-05	0.000185	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—CXCL8—atherosclerosis	6.56e-05	0.000185	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.49e-05	0.000183	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—F2—atherosclerosis	6.49e-05	0.000183	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—AGT—atherosclerosis	6.43e-05	0.000181	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—F2—atherosclerosis	6.41e-05	0.00018	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PRKCG—atherosclerosis	6.38e-05	0.00018	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PIK3CG—atherosclerosis	6.35e-05	0.000179	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—APOE—atherosclerosis	6.3e-05	0.000177	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CAV1—atherosclerosis	6.25e-05	0.000176	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—APOA1—atherosclerosis	6.23e-05	0.000175	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SPP1—atherosclerosis	6.22e-05	0.000175	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	6.21e-05	0.000175	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CXCL8—atherosclerosis	6.19e-05	0.000174	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	6.13e-05	0.000173	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PDGFB—atherosclerosis	6.1e-05	0.000172	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KNG1—atherosclerosis	6.06e-05	0.000171	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NAMPT—atherosclerosis	6.05e-05	0.00017	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AGTR1—atherosclerosis	6.03e-05	0.00017	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—LIPC—atherosclerosis	6.01e-05	0.000169	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APOC3—atherosclerosis	5.98e-05	0.000168	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AGT—atherosclerosis	5.96e-05	0.000168	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—LDLR—atherosclerosis	5.94e-05	0.000167	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KNG1—atherosclerosis	5.93e-05	0.000167	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CCL2—atherosclerosis	5.91e-05	0.000166	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	5.9e-05	0.000166	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PLG—atherosclerosis	5.87e-05	0.000165	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KNG1—atherosclerosis	5.86e-05	0.000165	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—APOE—atherosclerosis	5.84e-05	0.000164	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—LEP—atherosclerosis	5.84e-05	0.000164	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	5.82e-05	0.000164	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CETP—atherosclerosis	5.8e-05	0.000163	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	5.79e-05	0.000163	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CAV1—atherosclerosis	5.78e-05	0.000163	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—APOA1—atherosclerosis	5.77e-05	0.000162	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PDGFB—atherosclerosis	5.75e-05	0.000162	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PLG—atherosclerosis	5.75e-05	0.000162	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	5.71e-05	0.000161	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	5.7e-05	0.00016	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CG—atherosclerosis	5.69e-05	0.00016	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PLG—atherosclerosis	5.67e-05	0.00016	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AGT—atherosclerosis	5.62e-05	0.000158	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ESR1—atherosclerosis	5.57e-05	0.000157	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SOCS3—atherosclerosis	5.56e-05	0.000156	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SCARB1—atherosclerosis	5.56e-05	0.000156	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—LEP—atherosclerosis	5.5e-05	0.000155	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—F2—atherosclerosis	5.5e-05	0.000155	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—APOE—atherosclerosis	5.5e-05	0.000155	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PPARG—atherosclerosis	5.49e-05	0.000154	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CAV1—atherosclerosis	5.45e-05	0.000153	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	5.44e-05	0.000153	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—APOA1—atherosclerosis	5.44e-05	0.000153	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—INS—atherosclerosis	5.39e-05	0.000152	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	5.37e-05	0.000151	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MMP3—atherosclerosis	5.37e-05	0.000151	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IGF2—atherosclerosis	5.35e-05	0.00015	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CG—atherosclerosis	5.27e-05	0.000148	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MMP3—atherosclerosis	5.26e-05	0.000148	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ESR1—atherosclerosis	5.25e-05	0.000148	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—HMGCR—atherosclerosis	5.25e-05	0.000148	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IGF2—atherosclerosis	5.23e-05	0.000147	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APOB—atherosclerosis	5.19e-05	0.000146	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—F2—atherosclerosis	5.19e-05	0.000146	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MMP3—atherosclerosis	5.19e-05	0.000146	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF2—atherosclerosis	5.17e-05	0.000145	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CXCL8—atherosclerosis	5.15e-05	0.000145	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	5.14e-05	0.000145	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EDN1—atherosclerosis	5.11e-05	0.000144	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APOB—atherosclerosis	5.08e-05	0.000143	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL5—atherosclerosis	5.07e-05	0.000143	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—MAPK3—atherosclerosis	5.04e-05	0.000142	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	5.04e-05	0.000142	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APOB—atherosclerosis	5.02e-05	0.000141	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EDN1—atherosclerosis	5e-05	0.000141	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—INS—atherosclerosis	4.99e-05	0.00014	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	4.97e-05	0.00014	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CG—atherosclerosis	4.97e-05	0.00014	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL5—atherosclerosis	4.96e-05	0.00014	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—LPL—atherosclerosis	4.96e-05	0.000139	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—ALB—atherosclerosis	4.94e-05	0.000139	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EDN1—atherosclerosis	4.94e-05	0.000139	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCL2—atherosclerosis	4.91e-05	0.000138	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL5—atherosclerosis	4.9e-05	0.000138	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—LPL—atherosclerosis	4.85e-05	0.000136	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IGF1—atherosclerosis	4.82e-05	0.000136	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PRKCG—atherosclerosis	4.82e-05	0.000136	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LPL—atherosclerosis	4.79e-05	0.000135	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—MAPK3—atherosclerosis	4.76e-05	0.000134	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—NOS3—atherosclerosis	4.72e-05	0.000133	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	4.72e-05	0.000133	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—INS—atherosclerosis	4.7e-05	0.000132	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SPP1—atherosclerosis	4.69e-05	0.000132	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ABCA1—atherosclerosis	4.68e-05	0.000132	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CXCL8—atherosclerosis	4.67e-05	0.000132	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	4.66e-05	0.000131	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCL2—atherosclerosis	4.63e-05	0.00013	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SPP1—atherosclerosis	4.59e-05	0.000129	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SERPINE1—atherosclerosis	4.58e-05	0.000129	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	4.57e-05	0.000129	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IGF1—atherosclerosis	4.55e-05	0.000128	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SPP1—atherosclerosis	4.54e-05	0.000128	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	4.52e-05	0.000127	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NOS3—atherosclerosis	4.37e-05	0.000123	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PDGFB—atherosclerosis	4.34e-05	0.000122	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTGS2—atherosclerosis	4.32e-05	0.000122	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SERPINE1—atherosclerosis	4.32e-05	0.000121	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	4.25e-05	0.00012	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AGT—atherosclerosis	4.24e-05	0.000119	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	4.2e-05	0.000118	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APOE—atherosclerosis	4.15e-05	0.000117	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—LEP—atherosclerosis	4.15e-05	0.000117	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AGT—atherosclerosis	4.15e-05	0.000117	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NOS3—atherosclerosis	4.12e-05	0.000116	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CAV1—atherosclerosis	4.12e-05	0.000116	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APOA1—atherosclerosis	4.11e-05	0.000116	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AGT—atherosclerosis	4.1e-05	0.000115	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—LEP—atherosclerosis	4.07e-05	0.000114	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APOE—atherosclerosis	4.07e-05	0.000114	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CAV1—atherosclerosis	4.03e-05	0.000113	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APOA1—atherosclerosis	4.02e-05	0.000113	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APOE—atherosclerosis	4.01e-05	0.000113	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LEP—atherosclerosis	4.01e-05	0.000113	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—HMOX1—atherosclerosis	4.01e-05	0.000113	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CAV1—atherosclerosis	3.98e-05	0.000112	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APOA1—atherosclerosis	3.97e-05	0.000112	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ESR1—atherosclerosis	3.97e-05	0.000112	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—F2—atherosclerosis	3.92e-05	0.00011	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ESR1—atherosclerosis	3.88e-05	0.000109	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCL8—atherosclerosis	3.88e-05	0.000109	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APOB—atherosclerosis	3.84e-05	0.000108	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—F2—atherosclerosis	3.83e-05	0.000108	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ESR1—atherosclerosis	3.83e-05	0.000108	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—F2—atherosclerosis	3.79e-05	0.000107	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CG—atherosclerosis	3.75e-05	0.000105	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—AKT1—atherosclerosis	3.75e-05	0.000105	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTM1—atherosclerosis	3.74e-05	0.000105	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL6—atherosclerosis	3.69e-05	0.000104	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	3.67e-05	0.000103	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—LPL—atherosclerosis	3.67e-05	0.000103	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCL8—atherosclerosis	3.66e-05	0.000103	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	3.62e-05	0.000102	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	3.59e-05	0.000101	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GPX1—atherosclerosis	3.58e-05	0.000101	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—INS—atherosclerosis	3.55e-05	9.99e-05	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—AKT1—atherosclerosis	3.53e-05	9.94e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	3.51e-05	9.89e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MMP9—atherosclerosis	3.51e-05	9.87e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL2—atherosclerosis	3.49e-05	9.83e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CD36—atherosclerosis	3.49e-05	9.81e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL6—atherosclerosis	3.48e-05	9.78e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—INS—atherosclerosis	3.47e-05	9.77e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NFKB1—atherosclerosis	3.47e-05	9.76e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	3.47e-05	9.76e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IGF1—atherosclerosis	3.43e-05	9.66e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—INS—atherosclerosis	3.43e-05	9.65e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL2—atherosclerosis	3.42e-05	9.62e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MAPK8—atherosclerosis	3.41e-05	9.6e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—AKT1—atherosclerosis	3.4e-05	9.57e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL2—atherosclerosis	3.37e-05	9.49e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IGF1—atherosclerosis	3.36e-05	9.45e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF1—atherosclerosis	3.32e-05	9.33e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MMP9—atherosclerosis	3.31e-05	9.31e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—MTHFR—atherosclerosis	3.3e-05	9.3e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NFKB1—atherosclerosis	3.27e-05	9.21e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	3.26e-05	9.17e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPARA—atherosclerosis	3.24e-05	9.12e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MAPK8—atherosclerosis	3.22e-05	9.05e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—AKT1—atherosclerosis	3.21e-05	9.03e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	3.19e-05	8.98e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	3.15e-05	8.86e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—VEGFA—atherosclerosis	3.15e-05	8.86e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AGT—atherosclerosis	3.14e-05	8.83e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—STAT3—atherosclerosis	3.12e-05	8.77e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOS3—atherosclerosis	3.11e-05	8.76e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APOE—atherosclerosis	3.08e-05	8.65e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CAV1—atherosclerosis	3.05e-05	8.57e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOS3—atherosclerosis	3.05e-05	8.57e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APOA1—atherosclerosis	3.04e-05	8.55e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	3.01e-05	8.46e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MAPK3—atherosclerosis	2.98e-05	8.38e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—VEGFA—atherosclerosis	2.97e-05	8.36e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—STAT3—atherosclerosis	2.94e-05	8.27e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TGFB1—atherosclerosis	2.89e-05	8.13e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MAPK3—atherosclerosis	2.81e-05	7.91e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.78e-05	7.81e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCL8—atherosclerosis	2.76e-05	7.77e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TGFB1—atherosclerosis	2.73e-05	7.67e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	2.7e-05	7.6e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPARG—atherosclerosis	2.68e-05	7.54e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	2.67e-05	7.5e-05	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	2.67e-05	7.5e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—INS—atherosclerosis	2.63e-05	7.39e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6—atherosclerosis	2.63e-05	7.39e-05	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	2.61e-05	7.34e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	2.58e-05	7.25e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6—atherosclerosis	2.57e-05	7.23e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	2.54e-05	7.14e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MMP9—atherosclerosis	2.5e-05	7.03e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NFKB1—atherosclerosis	2.47e-05	6.95e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MMP9—atherosclerosis	2.44e-05	6.88e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MAPK8—atherosclerosis	2.43e-05	6.83e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AKT1—atherosclerosis	2.42e-05	6.81e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	2.42e-05	6.8e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	2.41e-05	6.79e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ALB—atherosclerosis	2.41e-05	6.78e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	2.39e-05	6.72e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	2.38e-05	6.69e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	2.37e-05	6.67e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	2.35e-05	6.6e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	2.34e-05	6.58e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NOS3—atherosclerosis	2.3e-05	6.48e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—VEGFA—atherosclerosis	2.24e-05	6.31e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—STAT3—atherosclerosis	2.22e-05	6.25e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	2.19e-05	6.17e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6—atherosclerosis	2.18e-05	6.13e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—STAT3—atherosclerosis	2.17e-05	6.11e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—AKT1—atherosclerosis	2.17e-05	6.11e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	2.17e-05	6.1e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	2.15e-05	6.04e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MAPK3—atherosclerosis	2.12e-05	5.97e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTGS2—atherosclerosis	2.11e-05	5.93e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	2.08e-05	5.84e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TGFB1—atherosclerosis	2.06e-05	5.79e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6—atherosclerosis	2.05e-05	5.78e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	2.05e-05	5.77e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	2.01e-05	5.67e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AKT1—atherosclerosis	2.01e-05	5.65e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	1.99e-05	5.59e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AKT1—atherosclerosis	1.9e-05	5.33e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6—atherosclerosis	1.55e-05	4.36e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6—atherosclerosis	1.52e-05	4.27e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6—atherosclerosis	1.5e-05	4.22e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT1—atherosclerosis	1.43e-05	4.03e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT1—atherosclerosis	1.4e-05	3.94e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.38e-05	3.89e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AKT1—atherosclerosis	1.06e-05	2.98e-05	CbGpPWpGaD
